Search

Your search keyword '"D. Richman"' showing total 2,789 results

Search Constraints

Start Over You searched for: Author "D. Richman" Remove constraint Author: "D. Richman"
2,789 results on '"D. Richman"'

Search Results

1. Enhanced production of 60Fe in massive stars

6. Fully transformer-based biomarker prediction from colorectal cancer histology: a large-scale multicentric study.

8. Molecular selection of therapy in metastatic colorectal cancer: the FOCUS4 molecularly stratified RCT

10. Integrated proteomics and transcriptomics analyses identify novel cell surface markers of HIV latency

16. Cover

19. Index

20. Notes

29. Data from In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal Cancer

30. Supplementary Results from In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal Cancer

31. Supplementary Data from Artificial Intelligence–Assisted Amphiregulin and Epiregulin IHC Predicts Panitumumab Benefit in RAS Wild-Type Metastatic Colorectal Cancer

32. supplementary figures, from In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal Cancer

33. Supplementary Table 1 from Mismatch Repair Status and BRAF Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS Studies

34. Data from Artificial Intelligence–Assisted Amphiregulin and Epiregulin IHC Predicts Panitumumab Benefit in RAS Wild-Type Metastatic Colorectal Cancer

35. Data from Mismatch Repair Status and BRAF Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS Studies

36. Supplementary Data from In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal Cancer

37. Development of the HIV360 international core set of outcome measures for adults living with HIV: A consensus process

38. Capecitabine Versus Active Monitoring in Stable or Responding Metastatic Colorectal Cancer After 16 Weeks of First-Line Therapy: Results of the Randomized FOCUS4-N Trial

39. Diagnostic Accuracy of Dried Plasma Spot Specimens for HIV-1 Viral Load Testing: A Systematic Review and Meta-analysis

40. Immunologic resilience and COVID-19 survival advantage

41. Clinical Features and Disease Management in Adult Patients With Atopic Dermatitis Receiving Care at Reference Hospitals in Brazil: the ADAPT Study

43. Artificial Intelligence–Assisted Amphiregulin and Epiregulin IHC Predicts Panitumumab Benefit in RAS Wild-Type Metastatic Colorectal Cancer

44. Angular analysis of the decay B+ → K∗(892)+ μ + μ − in proton-proton collisions at s $$ \sqrt{\mathrm{s}} $$ = 8 TeV

45. Telemedicine and Medical Licensure — Potential Paths for Reform

46. The Rise and Potential of Physician Unions

47. Clinical and molecular characteristics and treatment outcomes of advanced right-colon, left-colon and rectal cancers: data from 1180 patients in a phase III trial of panitumumab with an extended biomarker panel

48. Intact Human Immunodeficiency Virus (HIV) Reservoir Estimated by the Intact Proviral DNA Assay Correlates With Levels of Total and Integrated DNA in the Blood During Suppressive Antiretroviral Therapy

49. Assessing the Suitability of Next-Generation Viral Outgrowth Assays to Measure Human Immunodeficiency Virus 1 Latent Reservoir Size

50. Search for new neutral Higgs bosons through the H → ZA → ℓ + ℓ − b b ¯ $$ \mathrm{H}\to \mathrm{ZA}\to {\ell}^{+}{\ell}^{-}\mathrm{b}\overline{\mathrm{b}} $$ process in pp collisions at s $$ \sqrt{s} $$ = 13 TeV

Catalog

Books, media, physical & digital resources